# Clopidogrel + Acetylsalicylic acid

## CoPlavix 75/100mg

| TAH Drug Code      | [OCOP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCOP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Prevention of atherothrombotic events in adult patients already taking both clopidogrel + aspirin. Fixed-dose combination for continuation of therapy in: Non-ST-segment elevation acute coronary syndrome (unstable angina or non-Q-wave MI) including patients undergoing stent placement following percutaneous coronary intervention; ST-segment elevation acute MI in medically-treated patients eligible for thrombolytic therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | 75mg/100mg QD.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | This medication contains two active ingredients; therefore, CoPlavix is contraindicated in the following cases: ? Patients with hypersensitivity to the active ingredients or any excipients. ? Patients with severe hepatic impairment. ? Patients with active pathologic bleeding, such as gastric ulcers or intracranial hemorrhage. Additionally, due to the presence of ASA in this medication, it is also contraindicated in the following situations: ? Patients with hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) and those with asthma symptoms, rhinitis, or nasal polyps. ? Patients with mastocytosis, as ASA may trigger severe allergic reactions (including circulatory shock, accompanied by flushing, hypotension, tachycardia, and vomiting). ? Patients with severe renal impairment (creatinine clearance CrCl <30 ml/min). ? Women in the third trimester of pregnancy. |
| Adverse Effects    | Dyspepsia, abdominal pain, diarrhea; bleeding, hematoma, epistaxis; esophagitis, esophageal ulceration, perforation; fixed eruption.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | No (Limited) Human Data â€“ Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/clopidogrel-and-acetylsalicylic-acid-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

